Frostbite

disease
On this page

Summary

Frostbite (MONDO:0800177) is a disease and 8 clinical trials. Top therapeutic interventions include dalbavancin, oxygen, and aloe. A subtype of injury — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 8

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namefrostbite
Mondo IDMONDO:0800177
ICD-10-CMT33-T34
ICD-11152692065
NCITC34627
SNOMED CT370977006
Is cancer (heuristic)no

Disease family

This is a subtype of injury. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: injuryfrostbite

Related subtypes (9): ischemia reperfusion injury, bone fracture, acute lung injury, spinal injury, radiation injury, burn, ankle injury, nervous system injury, head injury

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 8.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified5
PHASE43

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06266494PHASE4RECRUITINGPrevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis
NCT07240649PHASE4NOT_YET_RECRUITINGOutcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
NCT07424378PHASE4NOT_YET_RECRUITINGEpoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)
NCT05777590Not specifiedACTIVE_NOT_RECRUITINGComparison of ICG Microangiography and Conventional Angiography in Severe Frostbite
NCT07450469Not specifiedNOT_YET_RECRUITINGField Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude
NCT03405467Not specifiedCOMPLETED10-years Nationwide Alpine Accidents in Austria
NCT04633174Not specifiedCOMPLETEDSous Vide Rewarming for Frostbitten Extremities
NCT05280301Not specifiedCOMPLETEDMulticenter Sous Vide Frostbite

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
DALBAVANCIN41
OXYGEN41
ALOE31
CHEMBL477823901
CHEMBL478539201
CHEMBL617470501